Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Regulation of the TGFβ signalling pathway by ubiquitin-mediated degradation

Oncogene volume 23, pages 2071–2078 (2004)Cite this article

Abstract

The transforming growth factor-β (TGFβ) superfamily controls a plethora of biological responses, and alterations in its signalling pathway are associated with a range of human diseases, including cancer. TGFβ superfamily ligands signal through a heteromeric complex of Ser/Thr kinase receptors that propagate the signal to the Smad family of intracellular proteins. The ubiquitin-mediated proteasomal degradation pathway is an evolutionary conserved cascade that tightly regulates TGFβ superfamily signalling. Both the size of the Smad pool in unstimulated cells and Smad protein levels subsequent to the activation of the pathway are controlled by ubiquitination. E3 ligases are components of the ubiquitin-degradation complex that specifically recognize targeted proteins and the E3 ligases, Smad ubiquitination-related factor 1 (Smurf1), Smurf2 and SCF/Roc1 have been implicated in Smad degradation. The Smurfs are of particular importance to TGFβ signalling, as Smads also function as adapters that recruit the Smurfs to various pathway components including the TGFβ receptor complex and the transcriptional repressor, SnoN, and thereby regulate the degradation of these Smad-associating proteins. Thus, by controlling the level of Smads as well as positive and negative regulators of the pathway, Smurfs provide for complex and fine control of signalling output. Finally, growing evidence demonstrates that ubiquitination and proteasomal degradation is also implicated in the turnover of tumor-derived Smad mutants and may thus contribute to disease progression.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Arora K, Levine M and O'Connor MB . (1994). Genes Dev., 8, 2588–2601.

  • Attisano L and Wrana JL . (2000). Curr. Opin. Cell. Biol., 12, 235–243.

  • Attisano L and Wrana JL . (2002). Science, 296, 1646–1647.

  • Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL and Arteaga CL . (2000). J. Biol. Chem., 275, 36803–36810.

  • Bhowmick NA, Ghiassim M, Bakin A, Aakre M, Lundquist CA, Engel ME, Arteaga CL and Moses HL . (2001). Mol. Cell. Biol., 12, 27–36.

  • Bonni S, Wang H-R, Causing CG, Kavsak P, Stroschein SL, Luo K and Wrana JL . (2001). Nat. Cell Biol., 3, 587–595.

  • de Caestecker MP, Piek E and Roberts AB . (2000). J. Natl. Cancer Inst., 92, 1388–1402.

  • Derynck R, Akhurst RJ and Balmain A . (2001). Nat. Genet., 29, 117–129.

  • Desterro JM, Rodriguez MS and Hay RT . (2000). Cell. Mol. Life Sci., 57, 1207–1219.

  • Di Guglielmo GM, Le Roy C, Goodfellow AF and Wrana JL . (2003). Nat. Cell Biol., 5, 410–421.

  • Dumont E, Lallemand F, Prunier C, Ferrand N, Guillouzo A, Clement B, Atfi A and Theret N . (2003). J. Biol. Chem., 278, 24881–24887.

  • Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T and Miyazono K . (2001). J. Biol. Chem., 276, 12477–12480.

  • Ehrlich M, Shmuely A and Henis YI . (2001). J. Cell Sci., 114, 1777–1786.

  • Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L-C, Bapat B, Gallinger S, Andrulis I, Thomsen G, Wrana JL and Attisano L . (1996). Cell, 86, 543–552.

  • Fukuchi M, Fukai Y, Masuda N, Miyazaki T, Nakajima M, Sohda M, Manda R, Tsukada K, Kato H and Kuwano H . (2002). Cancer Res., 62, 7162–7165.

  • Fukuchi M, Imamura T, Chiba T, Ebisawa T, Kawabata M, Tanaka K and Miyazono K . (2001). Mol. Cell. Biol., 12, 1430–1443.

  • Gronroos E, Hellman U, Heldin CH and Ericsson J . (2002). Mol. Cell, 10, 483–493.

  • Gruendler C, Lin Y, Farley J and Wang T . (2001). J. Biol. Chem., 276, 46533–46543.

  • Hayes S, Chawla A and Corvera S . (2002). J. Cell Biol., 158, 1239–1249.

  • Hershko A and Ciechanover A . (1998). Annu. Rev. Biochem., 67, 425–479.

  • Imoto S, Sugiyama K, Muromoto R, Sato N, Yamamoto T and Matsuda T . (2003). J. Biol. Chem., 278, 34253–34258.

  • Itoh S, Landstrom M, Hermansson A, Itoh F, Heldin C-H, Heldin N-E and ten Dijke P . (1998). J. Biol. Chem., 273, 29195–29201.

  • Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH and Wrana JL . (2000). Mol. Cell, 6, 1365–1375.

  • Lee PS, Chang C, Liu D and Derynck R . (2003). J. Biol. Chem., 278, 27853–27863.

  • Lin X, Liang M and Feng X-H . (2000). J. Biol. Chem., 275, 36818–36822.

  • Lin X, Liang M, Liang YY, Brunicardi FC and Feng XH . (2003a). J. Biol. Chem., 278, 31043–31048.

  • Lin X, Liang M, Liang YY, Brunicardi FC, Melchior F and Feng XH . (2003b). J. Biol. Chem., 278, 18714–18719.

  • Liu X, Elia AE, Law SF, Golemis EA, Farley J and Wang T . (2000). EMBO J., 19, 6759–6769.

  • Lo RS and Massagué J . (1999). Nat. Cell. Biol., 1, 472–478.

  • Long J, Matsuura I, He D, Wang G, Shuai K and Liu F . (2003). Proc. Natl. Acad. Sci. USA, 100, 9791–9796.

  • Lu Z, Murray JT, Luo W, Li H, Wu X, Xu H, Backer JM and Chen YG . (2002). J. Biol. Chem., 277, 29363–29368.

  • Massagué J . (1998). Annu. Rev. Biochem., 67, 753–791.

  • Maurice D, Pierreux CE, Howell M, Wilentz RE, Owen MJ and Hill CS . (2001). J. Biol. Chem., 276, 43175–43181.

  • Melchior F . (2000). Annu. Rev. Cell Dev. Biol., 16, 591–626.

  • Moren A, Hellman U, Inada Y, Imamura T, Heldin CH and Moustakas A . (2003). J. Biol. Chem., 278, 33571–33582.

  • Moren A, Itoh S, Moustakas A, Dijke P and Heldin CH . (2000). Oncogene, 19, 4396–4404.

  • Moustakas A, Souchelnytskyi S and Heldin C-H . (2001). J. Cell. Sci., 114, 4359–4369.

  • Mulder KM . (2000). Cytokine Growth Factor Rev., 11, 23–35.

  • Muller S, Hoege C, Pyrowolakis G and Jentsch S . (2001). Nat. Rev. Mol. Cell. Biol., 2, 202–210.

  • Murakami G, Watabe T, Takaoka K, Miyazono K and Imamura T . (2003). Mol. Cell. Biol., 14, 2809–2817.

  • Penheiter SG, Mitchell H, Garamszegi N, Edens M, Dore Jr JJ and Leof EB . (2002). Mol. Cell. Biol., 22, 4750–4759.

  • Podos SD, Hanson KK, Wang YC and Ferguson EL . (2001). Dev. Cell, 1, 567–578.

  • Saha D, Datta PK and Beauchamp RD . (2001). J. Biol. Chem., 276, 29531–29537.

  • Schwartz DC and Hochstrasser M . (2003). Trends Biochem. Sci., 28, 321–328.

  • Shi Y and Massague J . (2003). Cell, 113, 685–700.

  • Stroschein SL, Bonni S, Wrana JL and Luo K . (2001). Genes Dev., 15, 2822–2836.

  • Subramaniam V, Li HX, Wong M, Kitching R, Attisano L, Wrana JL, Zubovits J, Burger A and Seth A . (2003). Br. J. Cancer, 39, 1538–1544.

  • Suzuki C, Murakami G, Fukuchi M, Shimanuki T, Shikauchi Y, Imamura T and Miyazono K . (2002). J. Biol. Chem., 277, 39919–39925.

  • Tajima Y, Goto K, Yoshida M, Shinomiya K, Sekimoto T, Yoneda Y, Miyazono K and Imamura T . (2003). J. Biol. Chem., 278, 10716–10721.

  • ten Dijke P, Miyazono K and Heldin C-H . (2000). Trends Biochem. Sci., 25, 64–70.

  • Tsukazaki T, Chiang TA, Davison AF, Attisano L and Wrana JL . (1998). Cell, 95, 779–791.

  • Wan M, Cao X, Wu Y, Bai S, Wu L, Shi X, Wang N and Cao X . (2002). EMBO Rep., 3, 171–176.

  • Wan Y, Liu X and Kirschner MW . (2001). Mol. Cell, 8, 1027–1039.

  • Wang H-R, Zhang Y, Ozdamar B, Ogunjimi AO, Alexandrova E, Thomsen GH and Wrana JL . (2003). Science, 302, 1775–1779.

  • Whitman M . (1998). Genes Dev., 12, 2445–2462.

  • Wotton D and Massagué J . (2000). EMBO J., 19, 745–754.

  • Xu J and Attisano L . (2000). Proc. Natl. Acad. Sci. USA, 97, 4820–4825.

  • Ying SX, Hussain ZJ and Zhang YE . (2003). J. Biol. Chem., 278, 39029–39036.

  • Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A and Derynck R . (2001). Proc. Natl. Acad. Sci. USA, 98, 974–979.

  • Zhao M, Qiao M, Oyajobi BO, Mundy GR and Chen D . (2003). J. Biol. Chem., 278, 27939–27944.

  • Zhu H, Kavsak P, Abdollah S, Wrana JL and Thomsen GH . (1999). Nature, 400, 687–693.

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, University of Toronto, Toronto, M5S 1A8, Ontario, Canada

    Liliana Attisano

  2. Department of Medical Biophysics, University of Toronto, Toronto, M5S 1A8, Ontario, Canada

    Luisa Izzi & Liliana Attisano

Authors
  1. Luisa Izzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Liliana Attisano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Liliana Attisano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Izzi, L., Attisano, L. Regulation of the TGFβ signalling pathway by ubiquitin-mediated degradation. Oncogene 23, 2071–2078 (2004). https://doi.org/10.1038/sj.onc.1207412

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1207412

Keywords

This article is cited by

Search

Advanced search

Quick links